Patent to Bayer in conflict with the law
by Redaktion (comments: 0)
The European Patent Office in Munich has recently granted a patent for the German company Bayer for breeding plants with a higher stress tolerance (EP1616013), No Patents on Seeds reports. The comprehensive patent will give Bayer monopoly control over important food crops including both genetic engineering in plants and the process for conventional breeding and plants derived thereof.
Patents on processes for conventional breeding, based on crossing and selection, are in conflict with Article 53b of the European Patent Convention. This was confirmed by the EPO in a precedent decision at the end of 2010. However, in claim 14 of the Bayer patent nothing else is patented than conventional plant breeding based on natural genetic conditions.
“This new patent for Bayer breaks the law. It conflicts in particular with the prohibition of patents on essentially biological processes for breeding. This case shows once more that European Patent Law needs to be revised in order to effectively prohibit patents on the breeding of plants and animals. Further, the EPO must be subjected to independent control. If these kind of patents are not stopped, resources for daily living will be sold out to companies such as Bayer and Monsanto", warns Christoph Then, a representative of the international coalition “No Patents on Seeds”.
No Patents on Seeds
Kommentieren Sie den Artikel
Parts of the editorial content on this website are password-protected. If you have an already existing subscription to bio-markt.info the user access is unchanged, unless your user name consisted of BLANK SPACES or there were less than 8 characters in your password. You may continue to use your previous user name but omit any blank spaces. If your previous password had fewer than 8 characters please fill up this minimum using as many "0"s as necessary. Example: the user name "Naturkost Laden" is turned into "NaturkostLaden"; the password "salat" changes to "salat000". If you are not yet a subscriber to bio-markt.info but would like to access the password-protected editorial content in the future please register here.